We provide you with 20 years of free, institutional-grade data for RARE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RARE. Explore the full financial landscape of RARE stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1515673 | RARE | 10-Q | Url |
| 2025-05-07 | 1515673 | RARE | 10-Q | Url |
| 2025-02-19 | 1515673 | RARE | 10-K | Url |
| 2024-11-06 | 1515673 | RARE | 10-Q | Url |
| 2024-08-02 | 1515673 | RARE | 10-Q | Url |
| 2024-05-03 | 1515673 | RARE | 10-Q | Url |
| 2024-02-21 | 1515673 | RARE | 10-K | Url |
| 2023-11-03 | 1515673 | RARE | 10-Q | Url |
| 2023-08-04 | 1515673 | RARE | 10-Q | Url |
| 2023-05-05 | 1515673 | RARE | 10-Q | Url |
| 2023-02-17 | 1515673 | RARE | 10-K | Url |
| 2022-11-03 | 1515673 | RARE | 10-Q | Url |
| 2022-07-29 | 1515673 | RARE | 10-Q | Url |
| 2022-05-06 | 1515673 | RARE | 10-Q | Url |
| 2022-02-15 | 1515673 | RARE | 10-K | Url |
| 2021-11-03 | 1515673 | RARE | 10-Q | Url |
| 2021-08-03 | 1515673 | RARE | 10-Q | Url |
| 2021-05-05 | 1515673 | RARE | 10-Q | Url |
| 2021-02-12 | 1515673 | RARE | 10-K | Url |
| 2020-10-27 | 1515673 | RARE | 10-Q | Url |
| 2020-07-30 | 1515673 | RARE | 10-Q | Url |
| 2020-05-07 | 1515673 | RARE | 10-Q | Url |
| 2020-02-14 | 1515673 | RARE | 10-K | Url |
| 2019-11-06 | 1515673 | RARE | 10-Q | Url |
| 2019-08-02 | 1515673 | RARE | 10-Q | Url |
| 2019-05-07 | 1515673 | RARE | 10-Q | Url |
| 2019-02-20 | 1515673 | RARE | 10-K | Url |
| 2018-11-06 | 1515673 | RARE | 10-Q | Url |
| 2018-08-03 | 1515673 | RARE | 10-Q | Url |
| 2018-05-08 | 1515673 | RARE | 10-Q | Url |
| 2018-02-21 | 1515673 | RARE | 10-K | Url |
| 2017-11-03 | 1515673 | RARE | 10-Q | Url |
| 2017-07-28 | 1515673 | RARE | 10-Q | Url |
| 2017-05-05 | 1515673 | RARE | 10-Q | Url |
| 2017-02-17 | 1515673 | RARE | 10-K | Url |
| 2016-11-08 | 1515673 | RARE | 10-Q | Url |
| 2016-08-09 | 1515673 | RARE | 10-Q | Url |
| 2016-05-10 | 1515673 | RARE | 10-Q | Url |
| 2016-02-26 | 1515673 | RARE | 10-K | Url |
| 2015-11-10 | 1515673 | RARE | 10-Q | Url |
| 2015-08-14 | 1515673 | RARE | 10-Q | Url |
| 2015-05-12 | 1515673 | RARE | 10-Q | Url |
| 2015-03-27 | 1515673 | RARE | 10-K | Url |
| 2014-11-10 | 1515673 | RARE | 10-Q | Url |
| 2014-08-11 | 1515673 | RARE | 10-Q | Url |
| 2014-06-25 | 1515673 | RARE | S-1 | Url |
| 2014-05-12 | 1515673 | RARE | 10-Q | Url |
| 2014-03-24 | 1515673 | RARE | 10-K | Url |
| 2013-11-08 | 1515673 | RARE | S-1 | Url |
Ultragenyx Pharmaceutical Inc(NASDAQ:RARE) 
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibod...
Website: http://www.ultragenyx.com
Founded: 2010
Full Time Employees: 740
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about RARE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.